SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2011 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (230)7/7/2011 9:57:20 AM
From: A.J. Mullen   of 400
 
Insider selling is always worrying. I paused for thought before buying when reading about an ostentatious car (Ferrari or some sort) owned by a senior executive. At the time I decided that's just a symptom of the compensation of executives in start-ups, but maybe those tastes lead to selling at inopportune times.

I increased my holding to half a unit when the Pepsi deal was announced. I expected much more of a pop on that news. The prices seems to have moved more on SNMX's inclusion in the Russel 2000 and 3000 indices.

Jim, I don't know what their profit margins will be. Maybe less than pharma, but high nevertheless. I think of SNMX's enhancers as levers for sugar or salt. They will have many more consumers than for any pharmaceutical.

Ashley
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext